Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoti Apte

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Gastroenterology|August 1, 2025
Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased MetastasisS M Zahid Hosen, Ashna A Kumar, Zhihong Xu, et al.
Plos One|October 25, 2011
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interactionChristopher J Scarlett, Emily K Colvin, Mark Pinese, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 10, 2026
Epidemiological time trends in acute pancreatitis - A 16-year experience from South AustraliaEleonora Dal Grande, Jacqueline H Stephens, Mark E Brooke-Smith, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 17, 2026
Absolute risk of pancreatic cancer in people with acute pancreatitis - theAustralian experienceLucas Wigston, Eleonora D Grande, Jacqueline Stephens, et al.
Frontiers in Immunology|January 2, 2023
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)S M Zahid Hosen, Md Nazim Uddin, Zhihong Xu, et al.
The Journal of Pathology|December 22, 2018
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Chanthirika Ragulan, et al.
Journal of Medicinal Chemistry|August 22, 2018
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in CancerBenjamin J Buckley, Ashraf Aboelela, Elahe Minaei, et al.
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Alcohol, Clinical & Experimental Research|March 20, 2025
Differential impact of recent heavy drinking on first and recurrent acute pancreatitisChristie Y Jeon, Yu Ye, Georgios I Papachristou, et al.
Alcoholism, Clinical and Experimental Research|October 29, 2009
Alcohol, signaling, and ECM turnoverDevanshi Seth, Nympha B D'Souza El-Guindy, Minoti Apte, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Gastroenterology|August 1, 2025
Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased MetastasisS M Zahid Hosen, Ashna A Kumar, Zhihong Xu, et al.
Plos One|October 25, 2011
Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interactionChristopher J Scarlett, Emily K Colvin, Mark Pinese, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 10, 2026
Epidemiological time trends in acute pancreatitis - A 16-year experience from South AustraliaEleonora Dal Grande, Jacqueline H Stephens, Mark E Brooke-Smith, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 17, 2026
Absolute risk of pancreatic cancer in people with acute pancreatitis - theAustralian experienceLucas Wigston, Eleonora D Grande, Jacqueline Stephens, et al.
Frontiers in Immunology|January 2, 2023
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)S M Zahid Hosen, Md Nazim Uddin, Zhihong Xu, et al.
The Journal of Pathology|December 22, 2018
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Chanthirika Ragulan, et al.
Journal of Medicinal Chemistry|August 22, 2018
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in CancerBenjamin J Buckley, Ashraf Aboelela, Elahe Minaei, et al.
Nature Reviews. Disease Primers|May 7, 2026
Pancreatic cancerSusanne Roth, Minoti Apte, Vinod P Balachandran, et al.
Alcohol, Clinical & Experimental Research|March 20, 2025
Differential impact of recent heavy drinking on first and recurrent acute pancreatitisChristie Y Jeon, Yu Ye, Georgios I Papachristou, et al.
Alcoholism, Clinical and Experimental Research|October 29, 2009
Alcohol, signaling, and ECM turnoverDevanshi Seth, Nympha B D'Souza El-Guindy, Minoti Apte, et al.
Pageof 4